Development and Characterization of Monoclonal Antibodies against Nucleoprotein for Diagnosis of Influenza A Virus |
Nguyen, Hong Phuong
(Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology)
Kwak, Chaewon (Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology) Heo, Chang-Kyu (Rare Disease Research Center, Korea Research Institute of Bioscience and Biotechnology) Cho, Eun Wie (Rare Disease Research Center, Korea Research Institute of Bioscience and Biotechnology) Yang, Jihyun (Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology) Poo, Haryoung (Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology) |
1 | Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56: 152-179. |
2 | Cox NJ, Subbarao K. 1999. Influenza. Lancet 354: 1277-1282. DOI |
3 | Neumann G, Noda T, Kawaoka Y. 2009. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939. DOI |
4 | Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. 2007. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25: 5086-5096. DOI |
5 | Vemula SV, Zhao J, Liu J, Wang X, Biswas S, Hewlett I. 2016. Current approaches for diagnosis of influenza virus infections in humans. Viruses 8: 96. DOI |
6 | Kumar S, Henrickson KJ. 2012. Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin. Microbiol. Rev. 25: 344-361. DOI |
7 | Uyeki TM. 2003. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr. Infect. Dis. J. 22: 164-177. |
8 | Yang M, Berhane Y, Salo T, Li M, Hole K, Clavijo A. 2008. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein. J. Virol. Methods 147: 265-274. DOI |
9 | Falsey AR, Murata Y, Walsh EE. 2007. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch. Intern. Med. 167: 354-360. DOI |
10 | Mizuike R, Sasaki T, Baba K, Iwamoto H, Shibai Y, Kosaka M, et al. 2011. Development of two types of rapid diagnostic test kits to detect the hemagglutinin or nucleoprotein of the swine-origin pandemic influenza A virus H1N1. Clin. Vaccine Immunol. 18: 494-499. DOI |
11 | Drexler JF, Helmer A, Kirberg H, Reber U, Panning M, Muller M, et al. 2009. Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg. Infect. Dis. 15: 1662-1664. DOI |
12 | Uyeki TM, Prasad R, Vukotich C, Stebbins S, Rinaldo CR, Ferng YH, et al. 2009. Low sensitivity of rapid diagnostic test for influenza. Clin. Infect. Dis. 48: e89-e92. DOI |
13 | Linke S, Neubauer K, Dorner MB, Dorner BG, Pauli G, Schweiger B. 2011. Generation and characterisation of monoclonal antibodies against influenza virus A, subtype H5N1. J. Virol. Methods 175: 85-94. DOI |
14 | Wang W, Huang B, Jiang T, Wang X, Qi X, Gao Y, et al. 2012. Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coli. PLoS One 7: e52488. DOI |
15 | Yang J, Shim SM, Nguyen TQ, Kim EH, Kim K, Lim YT, et al. 2017. Poly-gamma-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine. Sci. Rep. 7: 44839. DOI |
16 | Polson A, Keen A, Sinclair-Smith C, Furminger IG. 1972. Polyethylene glycol purification of influenza virus with respect to aggregation and antigenicity. J. Hyg. (Lond.) 70: 255-265. DOI |
17 | Heo CK, Woo MK, Yu DY, Lee JY, Yoo JS, Yoo HS, et al. 2010. Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC. Int. J. Oncol. 36: 1453-1459. |
18 | Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P. 2008. Cellular proteins in influenza virus particles. PLoS Pathog. 4: e1000085. DOI |
19 | Heyward JT, Klimas RA, Stapp MD, Obijeski JF. 1977. The rapid concentration and purification of influenza virus from allantoic fluid. Arch. Virol. 55: 107-119. DOI |
20 | Shu LL, Bean WJ, Webster RG. 1993. Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990. J. Virol. 67: 2723-2729. |
21 | Reid AH, Fanning TG, Janczewski TA, Lourens RM, Taubenberger JK. 2004. Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. J. Virol. 78: 12462-12470. DOI |
22 | Babar MM, Zaidi NU. 2015. Protein sequence conservation and stable molecular evolution reveals influenza virus nucleoprotein as a universal druggable target. Infect. Genet. Evol. 34: 200-210. DOI |
23 | Ye Q, Krug RM, Tao YJ. 2006. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 444: 1078-1082. DOI |
24 | Werthen M, Nygren H. 1988. Effect of antibody affinity on the isotherm of antibody binding to surface-immobilized antigen. J. Immunol. Methods 115: 71-78. DOI |